Frontiers in surgery · 2026
Efficacy of anterior serratus plane block and intercostal nerve block in cardiothoracic surgery: a meta-analysis.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yuan Tao, Pan Meiyuan, Luo Yihan, Duan Dengke, Lai Shangdao
Аннотация
BACKGROUND: This study aims to evaluate the differences in analgesic efficacy between the SAPB and INB in cardiothoracic surgery through a meta-analysis.
METHODS: PubMed, Cochrane Library, Embase, and Web of Science were searched from the establishment of the databases until July 10, 2025. All randomized controlled trials (RCTs) comparing the efficacy of SAPB and INB in cardiothoracic surgery were included. Quality assessment was performed using risk of bias. All data were analyzed using Stata 15 software.
RESULTS: A total of 9 randomized controlled trials involving 606 patients were included, meta-analysis results indicated that no differences in 6-h pain scores [SMD = 0.28, 95% CI (-0.50, 1.06)], 12-h pain scores [SMD = -0.59, 95% CI (-1.71, 0.53)], 24-h pain scores [SMD = -0.07, 95% CI (-0.67, 0.52)], incidence of nausea and vomiting[RR = 0.84, 95% CI (0.27, 2.57)] and length of hospital stay [SMD = 0.01, 95% CI (-0.30, 0.32)]between the SAPB group and the INB group, However, compared with INB, SAPB may reduce total opioid consumption[SMD = -1.99, 95% CI (-3.21, -0.77)].
CONCLUSIONS: Overall, current evidence suggests that SAPB provides analgesic efficacy comparable to INB in cardiothoracic surgery. Subgroup analyses indicated that SAPB may be associated with lower pain scores in thoracotomy procedures and reduced opioid consumption in certain clinical settings; however, these findings should be interpreted cautiously due to heterogeneity across studies. Further high-quality randomized controlled trials are warranted to confirm these results.
SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251080642, PROSPERO CRD420251080642.
METHODS: PubMed, Cochrane Library, Embase, and Web of Science were searched from the establishment of the databases until July 10, 2025. All randomized controlled trials (RCTs) comparing the efficacy of SAPB and INB in cardiothoracic surgery were included. Quality assessment was performed using risk of bias. All data were analyzed using Stata 15 software.
RESULTS: A total of 9 randomized controlled trials involving 606 patients were included, meta-analysis results indicated that no differences in 6-h pain scores [SMD = 0.28, 95% CI (-0.50, 1.06)], 12-h pain scores [SMD = -0.59, 95% CI (-1.71, 0.53)], 24-h pain scores [SMD = -0.07, 95% CI (-0.67, 0.52)], incidence of nausea and vomiting[RR = 0.84, 95% CI (0.27, 2.57)] and length of hospital stay [SMD = 0.01, 95% CI (-0.30, 0.32)]between the SAPB group and the INB group, However, compared with INB, SAPB may reduce total opioid consumption[SMD = -1.99, 95% CI (-3.21, -0.77)].
CONCLUSIONS: Overall, current evidence suggests that SAPB provides analgesic efficacy comparable to INB in cardiothoracic surgery. Subgroup analyses indicated that SAPB may be associated with lower pain scores in thoracotomy procedures and reduced opioid consumption in certain clinical settings; however, these findings should be interpreted cautiously due to heterogeneity across studies. Further high-quality randomized controlled trials are warranted to confirm these results.
SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251080642, PROSPERO CRD420251080642.